Zevra Therapeutics, Inc.
ZVRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$106 | -$46 | -$42 | -$9 |
| Dep. & Amort. | $6 | $1 | $1 | $0 |
| Deferred Tax | $15 | $0 | $0 | $16 |
| Stock-Based Comp. | $15 | $6 | $4 | $2 |
| Change in WC | -$7 | $6 | -$0 | -$0 |
| Other Non-Cash | $6 | -$0 | $18 | $0 |
| Operating Cash Flow | -$70 | -$34 | -$19 | $10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | -$30 | -$14 | $0 |
| Inv. Purchases | -$41 | -$46 | -$23 | -$15 |
| Inv. Sales/Matur. | $25 | $59 | $37 | $0 |
| Other Inv. Act. | -$6 | $0 | -$37 | $0 |
| Investing Cash Flow | -$22 | -$17 | -$37 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $16 | $26 | $13 | -$38 |
| Stock Issued | $65 | $0 | $0 | $49 |
| Stock Repurch. | $0 | -$3 | -$5 | -$3 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $6 | $0 | $105 |
| Financing Cash Flow | $82 | $28 | $8 | $113 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9 | -$22 | -$47 | $108 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43 | $65 | $112 | $4 |
| End Cash | $34 | $43 | $65 | $112 |
| Free Cash Flow | -$70 | -$34 | -$19 | $10 |